WALL, NJ--(Marketwire - Oct 5, 2012) - BIO-key International, Inc. (OTCBB: [ BKYI ]), a global leader in fingerprint biometric identification solutions and advanced mobile identification technology, today reported that the company will be presenting at the American Association of Blood Banks - Annual Meeting and CTTXPO, at the Boston Convention Center, October 6^th - 9^th, 2012 (Booth # 1221). The event presents an opportunity for blood donor industry members to learn the about the latest advances in blood banking, transfusion medicine, cellular therapies and to explore state-of-the-art products and services.

Eric Schulties, CIO at the Institute for Transfusion Medicine and winner of the CIO of the Year 2012 award in Pittsburg, Pennsylvania, will be directing and Michele Tysarczyk, RN, BA, Executive Director, Blood Operations at [ Central Blood Bank ], will be moderating a discussion for Nurses, Managers/Supervisors, and CEOs/CFOs. The panel of speakers will include Anne Lassinger, BS, MT (ASCP); Mary Plut, MT (ASCP), CQE (ASQ); Eric Schulties, MBA, MHA; Roxanne Tata, MT(ASCP)SBB, CQA (ASQ).

This forum opens with an overview of how one organization moved from a first-stage electronic donor record to a more advanced system that includes biometrics for donor and staff identification. Panelists will discuss the integration process with third-party medical devices, along with the overall impact these projects had on key performance indicators, such as duplicate donors and documentation errors. Topics covered will include: why biometrics and integration with medical devices were selected as strategic projects, how these projects were set up and positioned for success, and finally the group will share the key technology, process and organization decisions that were made. Speakers will highlight how this organization prepared for the culture shift, trained and retooled its workforce to embrace these new technologies and workflow. Donor and employee perception of and response to these technological and process changes and the strategies adopted to encourage employee and donor acceptance will also be discussed. If your organization is considering integrating biometric technology, this session is critical in aiding your understanding of how biometrics can improve your outcomes based upon the real world experiences of your industry colleagues.

About BIO-key
BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers. BIO-key's award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world's largest identification deployments to improve security, guarantee identity, and help reduce identity theft. BIO-key's technology is offered directly or by market leading partners around the world. ([ http://www.bio-key.com ])

BIO-key Safe Harbor Statement
Certain statements contained in this press release may be construed as "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, the impact on our business of the recent financial crisis in the global capital markets and negative global economic trends, our ability to attract and retain key personnel. For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2011 and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. The Company also undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.